Diaceutics Plc Stock Performance
| DIUXF Stock | USD 1.67 0.00 0.00% |
On a scale of 0 to 100, Diaceutics PLC holds a performance score of 10. The firm shows a Beta (market volatility) of -0.13, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Diaceutics PLC are expected to decrease at a much lower rate. During the bear market, Diaceutics PLC is likely to outperform the market. Please check Diaceutics PLC's risk adjusted performance, variance, as well as the relationship between the Variance and kurtosis , to make a quick decision on whether Diaceutics PLC's price patterns will revert.
Risk-Adjusted Performance
Fair
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Diaceutics PLC are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Diaceutics PLC reported solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 25.3 M | |
| Total Cashflows From Investing Activities | -5.6 M |
Diaceutics |
Diaceutics PLC Relative Risk vs. Return Landscape
If you would invest 137.00 in Diaceutics PLC on November 8, 2025 and sell it today you would earn a total of 30.00 from holding Diaceutics PLC or generate 21.9% return on investment over 90 days. Diaceutics PLC is currently producing 0.359% returns and takes up 2.8037% volatility of returns over 90 trading days. Put another way, 25% of traded pink sheets are less volatile than Diaceutics, and 93% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Diaceutics PLC Target Price Odds to finish over Current Price
The tendency of Diaceutics Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.67 | 90 days | 1.67 | roughly 2.28 |
Based on a normal probability distribution, the odds of Diaceutics PLC to move above the current price in 90 days from now is roughly 2.28 (This Diaceutics PLC probability density function shows the probability of Diaceutics Pink Sheet to fall within a particular range of prices over 90 days) .
Diaceutics PLC Price Density |
| Price |
Predictive Modules for Diaceutics PLC
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Diaceutics PLC. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Diaceutics PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Diaceutics PLC Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Diaceutics PLC is not an exception. The market had few large corrections towards the Diaceutics PLC's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Diaceutics PLC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Diaceutics PLC within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.33 | |
β | Beta against Dow Jones | -0.13 | |
σ | Overall volatility | 0.12 | |
Ir | Information ratio | 0.11 |
Diaceutics PLC Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Diaceutics PLC for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Diaceutics PLC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Diaceutics PLC may become a speculative penny stock | |
| About 47.0% of the company shares are held by company insiders |
Diaceutics PLC Fundamentals Growth
Diaceutics Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Diaceutics PLC, and Diaceutics PLC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Diaceutics Pink Sheet performance.
| Return On Equity | 0.0032 | |||
| Return On Asset | 3.0E-4 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0 % | |||
| Current Valuation | 54.7 M | |||
| Shares Outstanding | 84.47 M | |||
| Price To Earning | 112.00 X | |||
| Price To Book | 2.07 X | |||
| Price To Sales | 6.10 X | |||
| Revenue | 13.94 M | |||
| EBITDA | 2.35 M | |||
| Cash And Equivalents | 19.68 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 1.56 M | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 0.49 X | |||
| Cash Flow From Operations | 570 K | |||
| Earnings Per Share | 0.01 X | |||
| Total Asset | 45.01 M | |||
About Diaceutics PLC Performance
By analyzing Diaceutics PLC's fundamental ratios, stakeholders can gain valuable insights into Diaceutics PLC's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Diaceutics PLC has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Diaceutics PLC has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom. Diaceutics Plc is traded on OTC Exchange in the United States.Things to note about Diaceutics PLC performance evaluation
Checking the ongoing alerts about Diaceutics PLC for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Diaceutics PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Diaceutics PLC may become a speculative penny stock | |
| About 47.0% of the company shares are held by company insiders |
- Analyzing Diaceutics PLC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Diaceutics PLC's stock is overvalued or undervalued compared to its peers.
- Examining Diaceutics PLC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Diaceutics PLC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Diaceutics PLC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Diaceutics PLC's pink sheet. These opinions can provide insight into Diaceutics PLC's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Diaceutics Pink Sheet analysis
When running Diaceutics PLC's price analysis, check to measure Diaceutics PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diaceutics PLC is operating at the current time. Most of Diaceutics PLC's value examination focuses on studying past and present price action to predict the probability of Diaceutics PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diaceutics PLC's price. Additionally, you may evaluate how the addition of Diaceutics PLC to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |